Fjarde AP Fonden Fourth Swedish National Pension Fund Raises Holdings in The Allstate Co. (NYSE:ALL)

Fjarde AP Fonden Fourth Swedish National Pension Fund grew its position in shares of The Allstate Co. (NYSE:ALL) by 30.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 72,155 shares of the insurance provider’s stock after buying an additional 16,700 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Allstate were worth $13,911,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Howard Capital Management Inc. lifted its holdings in Allstate by 5.2% during the 4th quarter. Howard Capital Management Inc. now owns 1,711 shares of the insurance provider’s stock worth $330,000 after purchasing an additional 85 shares in the last quarter. Fisher Funds Management LTD purchased a new stake in Allstate during the 4th quarter worth about $11,177,000. First Horizon Advisors Inc. lifted its holdings in Allstate by 0.7% during the 4th quarter. First Horizon Advisors Inc. now owns 72,603 shares of the insurance provider’s stock worth $13,997,000 after purchasing an additional 495 shares in the last quarter. Pinnacle Financial Partners Inc lifted its holdings in Allstate by 2.1% during the 4th quarter. Pinnacle Financial Partners Inc now owns 15,252 shares of the insurance provider’s stock worth $2,935,000 after purchasing an additional 317 shares in the last quarter. Finally, Sigma Planning Corp lifted its holdings in Allstate by 5.1% during the 4th quarter. Sigma Planning Corp now owns 4,131 shares of the insurance provider’s stock worth $797,000 after purchasing an additional 200 shares in the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Allstate Price Performance

Shares of Allstate stock opened at $185.51 on Monday. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $49.12 billion, a PE ratio of 10.92, a price-to-earnings-growth ratio of 1.03 and a beta of 0.52. The business’s 50-day moving average price is $190.25 and its 200-day moving average price is $190.43. The Allstate Co. has a 12 month low of $153.87 and a 12 month high of $209.88.

Allstate (NYSE:ALL) last announced its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, beating the consensus estimate of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. Sell-side analysts forecast that The Allstate Co. will post 18.65 EPS for the current fiscal year.

Insider Activity

In related news, CFO Jesse E. Merten sold 40,102 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the transaction, the chief financial officer now directly owns 18,115 shares in the company, valued at $3,378,990.95. This trade represents a 68.88 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.80% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Keefe, Bruyette & Woods increased their price objective on Allstate from $235.00 to $240.00 and gave the stock an “outperform” rating in a report on Tuesday, February 11th. The Goldman Sachs Group increased their price objective on Allstate from $209.00 to $230.00 and gave the stock a “buy” rating in a report on Friday, November 15th. Piper Sandler increased their price objective on Allstate from $206.00 to $244.00 and gave the stock an “overweight” rating in a report on Tuesday, November 26th. Morgan Stanley upped their target price on Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a research note on Thursday, November 7th. Finally, UBS Group upped their target price on Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $217.94.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.